A Senate panel began exploring issues surrounding medical marijuana as lawmakers prepare to carry out a constitutional amendment overwhelmingly approved by voters in November.
The Senate Health Policy Committee heard from a cannabis vendor, patient advocates, doctors and opponents of Amendment 2, which legalized medical marijuana for a broad swath of patients and set Florida in position to become one of the largest pot markets in the nation.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
